Ex Parte Sugaya et al - Page 11




               Appeal No. 2005-1907                                                                      Page 11                 
               Application No. 09/909,898                                                                                        


               1984).  Rebuttal may take the form of a comparison with the prior art showing that any                            
               differences are not merely normal expected variations but would have been unexpected by those                     
               of ordinary skill in the art.  See In re Mayne, 104 F.3d 1339, 1342, 41 USPQ2d 1451, 1454 (Fed.                   
               Cir. 1997); In re Freeman, 474 F.2d 1318, 1324, 177 USPQ 139, 143 (CCPA 1973).  Appellants                        
               make a comparison between membranes made with a C1 group as “A” in formula (2) as in                              
               Terada and MacDonald versus a C4 group, as “A” as encompassed by the claim.  We agree with                        
               Appellants that such a comparison reflects the closest prior art, but this single comparison is not               
               commensurate-in-scope with the claims.  The claims encompass many other monomers and                              
               Appellants provide no evidence that the results would be similar for the other monomers.                          
               Furthermore, Appellants have not convinced us that the differences in heat durability and other                   
               properties discussed in the Brief and Reply Brief would not have been expected by one of                          
               ordinary skill in the art.  There is no statement in the specification that the variations would have             
               been unexpected.  Moreover, as evidenced by Tomoi, heat durability was known to be improved                       
               with the use of the monomers in which n is from 3 to 18, i.e., “A” is a C3-18 group.                              
               Remand to the Examiner                                                                                            
                      We also remand this application to the Examiner to consider a rejection including                          
               MacDonald and Tomoi as evidence of unpatentability with regard to the product claims 1-4, 11,                     
               and 12.  As discussed in regard to the process claims, the evidence supports the finding that there               
               is a suggestion to use the precursor monomer of Tomoi (col. 5, ll. 28-45) in the method of                        
               MacDonald (col. 8, ll. 5-24 referencing col. 7, ll. 42-47) to make an anion selective membrane                    







Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007